Longterm Efficacy and Safety of NVP-Based HAART in HIV-1 Positive Patients in the Daily Clinical Practice.
Phase of Trial: Phase IV
Latest Information Update: 05 May 2014
At a glance
- Drugs Nevirapine (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 10 Jun 2017 Biomarkers information updated
- 21 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Aug 2011 Planned end date changed from Jul 2011 to Sep 2011 as reported by ClinicalTrials.gov.